L-homoarginine is associated with decreased cardiovascular- and all-cause mortality.
Maserame Cleopatra MokhaneliShani Botha-Le RouxCarla Maria Theresia FourieRainer H BögerEdzard SchwedhelmCatharina Martha Cornelia MelsPublished in: European journal of clinical investigation (2020)
Higher L-homoarginine levels are associated with reduced risk of 10-year cardiovascular and all-cause mortality. Regulation of L-homoarginine levels as a therapeutic target in the management of cardiovascular disease should be investigated.